News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
2,723 Results
Type
Article (253)
Press Release (2470)
Section
Business (1016)
Deals (122)
Drug Development (523)
Employer Resources (1)
FDA (94)
Job Trends (50)
News (1703)
Policy (122)
Tag
Academia (17)
Alliances (339)
ALS (2)
Alzheimer's disease (10)
Approvals (94)
Artificial intelligence (1)
Autoimmune disease (4)
Bankruptcy (1)
Best Places to Work (38)
BIOSECURE Act (1)
Biosimilars (1)
Breast cancer (2)
Cancer (9)
Cardiovascular disease (1)
CAR-T (4)
Cell therapy (6)
Clinical research (454)
Collaboration (4)
COVID-19 (9)
C-suite (8)
Data (27)
Diagnostics (4)
Diversity, equity & inclusion (1)
Drug discovery (2)
Drug pricing (1)
Earnings (288)
Editorial (1)
Employer resources (1)
Events (295)
Executive appointments (11)
FDA (101)
Funding (4)
Gene therapy (1)
GLP-1 (4)
Government (9)
Guidances (2)
Healthcare (40)
IgA nephropathy (1)
Immunology and inflammation (12)
Indications (1)
Infectious disease (10)
Inflammatory bowel disease (1)
IPO (41)
IRA (1)
Job creations (14)
JPM (1)
Legal (27)
Lymphoma (3)
Manufacturing (1)
Medical device (12)
Medtech (12)
Mergers & acquisitions (82)
Metabolic disorders (1)
Multiple sclerosis (2)
Neurodegenerative disease (10)
Neuropsychiatric disorders (1)
Neuroscience (20)
NextGen: Class of 2026 (31)
Non-profit (14)
Obesity (1)
Opinion (1)
Pain (1)
Parkinson's disease (3)
Patient recruitment (1)
People (358)
Phase 1 (96)
Phase 2 (166)
Phase 3 (221)
Pipeline (22)
Policy (2)
Postmarket research (39)
Preclinical (30)
Radiopharmaceuticals (2)
Rare diseases (6)
Real estate (23)
Regulatory (103)
Research institute (9)
RSV (1)
Schizophrenia (1)
Series A (1)
Series B (1)
Spinal muscular atrophy (1)
Startups (14)
The Weekly (1)
Vaccines (1)
Venture capital (1)
Weight loss (1)
Date
Last 30 days (4)
Last 365 days (91)
2026 (7)
2025 (98)
2024 (120)
2023 (92)
2022 (194)
2021 (176)
2020 (175)
2019 (156)
2018 (125)
2017 (174)
2016 (168)
2015 (191)
2014 (170)
2013 (103)
2012 (112)
2011 (121)
2010 (101)
Location
Africa (4)
Asia (90)
Australia (10)
California (11)
Canada (7)
China (2)
Delaware (7)
Europe (973)
Georgia (24)
Idaho (3)
Indiana (3)
Japan (3)
Massachusetts (29)
New Jersey (6)
New York (16)
Northern California (9)
Ohio (1)
Pennsylvania (1)
South America (6)
Texas (4)
United States (103)
Virginia (1)
Washington State (4)
2,723 Results for "ucb".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Citizen Health Joins Forces with UCB to Accelerate Drug Development across Epilepsy and Rare Diseases
December 3, 2025
·
4 min read
Rare diseases
UCB Wins First FDA Approval for Ultra-Rare Mitochondrial Disease
Kygevvi is indicated for patients with thymidine kinase 2 deficiency whose symptoms arise by 12 years of age. The disease manifests as muscle weakness and can become life-threatening in severe instances.
November 4, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Lee’s Pharmaceutical Holdings Limited Acquires Staccato® One Breath Technology® Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights
December 10, 2025
·
6 min read
Press Releases
UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder
December 8, 2025
·
6 min read
Press Releases
UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduced countable motor seizure frequency in CDKL5 deficiency disorder
December 8, 2025
·
16 min read
Press Releases
UCB to unveil new data for RYSTIGGO® (rozanolixizumab-noli) and ZILBRYSQ®(zilucoplan) for gMG at the 2025 AANEM Annual Meeting and MGFA Scientific Session
October 29, 2025
·
22 min read
Alzheimer’s disease
Roche Trims Another Alzheimer’s Prospect, Ending UCB Collabortion
Roche drops a third Alzheimer’s candidate this year, terminating a partnership with UCB just four years after agreeing to work together on new treatments for the neurological disease.
October 22, 2024
·
1 min read
·
Annalee Armstrong
Press Releases
UCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress
August 29, 2025
·
40 min read
Immunology and inflammation
Biogen, UCB Reveal Details Behind Surprise Late-Stage Win in Lupus, Eye Second Phase III
After the unexpected success of their PHOENYCS GO study for dapirolizumab pegol in lupus earlier this fall, Biogen and UCB are planning a second late-stage trial by the end of the year to support a drug application.
November 19, 2024
·
3 min read
·
Tristan Manalac
Mergers & acquisitions
UCB Offloads Neurology, Allergy Portfolio in China for $680M
Belgium-based biopharma UCB is selling its Chinese neurology and allergy business to Singapore asset management firm CBC Group and Abu Dhabi investment company Mubadala.
August 26, 2024
·
1 min read
·
Annalee Armstrong
1 of 273
Next
